DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Issue 10 · Volume 47 · September 2015 DOI: 10.1055/s-005-30121 Autoimmune Thyroid Diseases

Erratum

e4
Banga, J. P.; Moshkelgosha, S.; Berchner-Pfannschmidt, U.; Eckstein, A.: Modeling Graves’ Orbitopathy in Experimental Graves’ Disease

Editorial

699
Banga, J. P.; Schott, M.: Autoimmune Thyroid Diseases

Review

702
Ajjan, R. A.; Weetman, A. P.: The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding
711
Kong, Y. M.; Brown, N. K.; Morris, G. P.; Flynn, J. C.: The Essential Role of Circulating Thyroglobulin in Maintaining Dominance of Natural Regulatory T Cell Function to Prevent Autoimmune Thyroiditis
721
Duntas, L. H.: The Role of Iodine and Selenium in Autoimmune Thyroiditis
727
Morshed, S. A.; Davies, T. F.: Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
735
Furmaniak, J.; Sanders, J.; Núñez Miguel, R.; Rees Smith, B.: Mechanisms of Action of TSHR Autoantibodies
753
Pujol-Borrell, R.; Giménez-Barcons, M.; Marín-Sánchez, A.; Colobran, R.: Genetics of Graves’ Disease: Special Focus on the Role of TSHR Gene
767
Piantanida, E.; Lai, A.; Sassi, L.; Gallo, D.; Spreafico, E.; Tanda, M. L.; Bartalena, L.: Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs
773
Bahn, R. S.: Current Insights into the Pathogenesis of Graves’ Ophthalmopathy
779
Salvi, M.; Campi, I.: Medical Treatment of Graves’ Orbitopathy
789
Neumann, S.; Place, R. F.; Krieger, C. C.; Gershengorn, M. C.: Future Prospects for the Treatment of Graves’ Hyperthyroidism and Eye Disease
797
Banga, J. P.; Moshkelgosha, S.; Berchner-Pfannschmidt, U.; Eckstein, A.: Modeling Graves’ Orbitopathy in Experimental Graves’ Disease